Primary HIV infection in infants: Impact of highly active antiretroviral therapy on the natural course

Journal of Biological Regulators and Homeostatic Agents

Volumn 16, Issue 1, 2002, Pages 53-57

  De Rossi, A ^a  

^a Centro AIDS   (Italy)

Author keywords

Highly active antiretroviral therapy; HIV perinatal transmission; Primary infection

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DELIVERY; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFANT; PERINATAL INFECTION; PREDICTION; PREGNANCY; PRIMARY INFECTION; VERTICAL TRANSMISSION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0036255711     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
2. Biological and virological characteristics of primary HIV infection
3. Murine and simian retrovirus models: The threshold hypothesis
4. Clearance of HIV infection in a perinatally infected infant
5. 9-year old child falling CD4 count after neonatal HIV
6. Clearance of HIV infection in 12 perinatally infected children: Clinical, virological and immunological data
7. Detection of virus in vertically exposed HIV antibody negative children
8. Immune responses in HIV-exposed seronegatives: Have they repelled the virus?
9. Short-course zidovudine for perinatal HIV-1 transmission in Thailand: A randomised controlled trial
10. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus
11. Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection
12. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease
13. Viral phenotype in mother to child transmission and disease progression
14. Aspetti virologici e fattori genetici dell'ospite nella trasmissione verticale del virus della immuno-deficienza acquisita
15. Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease
16. Co-receptor usage of HIV-1 primary islates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission
17. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life
18. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
19. Restriction of HIV-1 infection in macrophages heterozygous for a deletion in the CC-ckemokine receptor 5 gene
20. Genetic acceleration of AIDS progression by a promoter variant of CCR5
21. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected infants
22. Immune restoration with antiretroviral therapies
23. Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection
24. Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS
25. Early short-term 9-2-R phosphonometoxy propyladenine treatment favourably alters the subsequent disease course in simian immunodeficiency virus-infected newborn rhesus macaques
26. Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: Control of viral replication and absence of persistent HIV-1 specific immune responses
27. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses